PEG-MGF (Pegylated MGF)

Pegylated Mechano Growth Factor | IGF-1 Splice Variant

Weight: ~2,888 Da
Half-life: 48-72 hours (via PEGylation)
Chain: 24 amino acids
3 studies
2018 latest
limited
Dose 200-400mcg per injection
Frequency 2-3x weekly, ideally post-workout
Cycle 4-8 weeks
Storage Refrigerate at 2-8°C; protect from light

Community Research

Join others researching PEG-MGF — share findings, ask questions, and learn from real experiences

Modified IGF-1 variant with PEG attachment extending half-life from minutes to hours. Activates muscle satellite cells following mechanical stress or injury.

Mechanism of Action

Activates muscle satellite stem cells via receptor binding, stimulating MAPK/ERK signaling. Enhances protein synthesis and promotes muscle fiber repair. E-peptide domain exhibits distinct activity from mature IGF-1.

01 Extended half-life through PEGylation
02 Satellite cell activation for muscle repair
03 Recovery support following mechanical stress
04 Potential neuroprotection against oxidative stress

Molecular Data

Molecular Weight
~2,888 Da
Chain Length
24 amino acids
Type
IGF-1Ec splice variant C-terminal peptide
Amino Acid Sequence
YQPPSTNKNTKSQRRKGSTFEEHK

Complex or non-standard sequence format

Peak 0.0 mcg
Trough 0.0 mcg
SS Peak 0.0 mcg
SS Trough 0.0 mcg

Research Indications

Muscle Repair
Satellite Cell Activation most effective

Primary mechanism activating dormant muscle satellite cells which fuse to damaged fibers.

Delayed Senescence effective

Increases proliferative lifespan in younger muscle progenitor cells.

Enhanced Fusion Potential effective

Increases activated satellite cell fusion capacity supporting repair and hypertrophy.

Tissue Regeneration
Tendon Healing effective

Animal studies suggest improved Achilles tendon injury outcomes.

Bone Regeneration moderate

Rabbit models demonstrated faster healing via osteoblast regulation.

Cartilage Repair moderate

Research indicates potential for articular cartilage injury models.

Recovery
Exercise Recovery moderate

Naturally upregulated after mechanical stress; supplementation may enhance processes.

Injury Recovery effective

Localized injection near injury sites supports targeted tissue repair.

Dosing Protocols

Subcutaneous or intramuscular administration; post-workout timing aligns with natural MGF upregulation.

GoalDoseFrequencyRoute
General Recovery200mcg2-3x weeklySubQ or IM
Targeted Muscle Recovery200-400mcgPost-workout, 2-3x weeklyIM bilateral near target muscle
Injury Recovery200-400mcg2-3x weeklyIM near injury site
Conservative Protocol100-200mcg2x weeklySubQ

Reconstitution Instructions

Materials Needed:
  • PEG-MGF lyophilized powder (typically 2mg vial)
  • Bacteriostatic water
  • Insulin syringes (29-31 gauge)
  • Alcohol swabs
  1. 1 Allow vial to reach room temperature
  2. 2 Clean rubber stopper with alcohol swab
  3. 3 Draw appropriate bacteriostatic water amount
  4. 4 Inject slowly along vial wall, not directly onto powder
  5. 5 Gently swirl to dissolve; never shake
  6. 6 Allow 2-5 minutes for full dissolution
  7. 7 Store refrigerated at 2-8°C
  8. 8 Protect from light

Interactions

~
IGF-1 LR3
Both target IGF-1 pathways; combining risks receptor overstimulation. Reduce doses significantly if combined.
monitor
~
Human Growth Hormone
HGH increases endogenous IGF-1/MGF. Combined use amplifies effects but monitor for excessive water retention and joint pain.
monitor
++
BPC-157
Complementary mechanisms. BPC-157 promotes angiogenesis; PEG-MGF activates satellite cells. Popular recovery stack.
synergistic
++
TB-500
TB-500 reduces inflammation and promotes cell migration; PEG-MGF activates muscle stem cells.
synergistic
~
Insulin
Both affect glucose metabolism. Monitor blood sugar carefully if combined.
monitor
++
Thymosin Beta-4
Different regenerative pathways may enhance tissue repair through multiple mechanisms.
synergistic

What to Expect

Week 1-2
Reduced muscle soreness post-workout; subtle recovery improvements
Week 2-4
Enhanced recovery between training; potential injury-related discomfort reduction
Week 4-8
Optimal muscle repair effects; improved training capacity from better recovery
Post-cycle
Benefits persist several weeks as tissue repair continues

Side Effects & Safety

Common Side Effects

  • Injection site soreness
  • Mild fatigue

Stop Signs - Discontinue if:

  • Any unusual growths, lumps, or rapid tissue changes
  • Severe injection site reactions beyond normal soreness
  • Persistent headaches or vision changes
  • Signs of hypoglycemia
  • Unexpected swelling or edema

Contraindications

  • Any history of cancer or neoplastic disease
  • Pregnancy or breastfeeding
  • Uncontrolled diabetes or severe hyperglycemia

Quality Checklist

Good Signs

  • White or off-white fluffy cake appearance indicates proper freeze-drying
  • Crystal clear solution after reconstitution with no particles
  • Certificate of Analysis with HPLC purity testing (>98%)

Warning Signs

  • Minor clumping that dissolves with gentle swirling is normal

Bad Signs

  • Collapsed or discolored powder suggests heat degradation
  • Persistent cloudiness or visible particles indicate contamination

References

  • MGF-E Peptide Human Muscle Cell Study
    (2011)

    Landmark study demonstrating MGF significantly increased satellite cell proliferation at 3ng/ml (P<0.001) with age-dependent effects.

  • MGF Inflammatory Response Study
    (2018)

    MGF overexpression modulated inflammatory cytokines and enhanced macrophage resolution during skeletal muscle injury recovery.

  • Mechano-Growth Factor Minireview
    (2010)

    Overview of MGF as IGF-I gene product involved in tissue repair, highlighting upregulation following exercise and injury.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.